Source:http://linkedlifedata.com/resource/pubmed/id/18431362
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-5-26
|
pubmed:abstractText |
The effectiveness of the dendritic cell (DC) vaccination protocols that are currently in use could be improved by providing the DCs with a more potent maturation signal. We therefore investigated whether the T-cell stimulatory capacity of human monocyte-derived DCs could be increased by co-electroporation with different combinations of CD40L, CD70, and constitutively active toll-like receptor 4 (caTLR4) encoding mRNA. We show that immature DCs electroporated with CD40L and/or caTLR4 mRNA, but not those electroporated with CD70 mRNA, acquire a mature phenotype along with an enhanced secretion of several cytokines/chemokines. Moreover, these DCs are very potent in inducing naive CD4(+) T cells to differentiate into interferon-gamma (IFN-gamma)-secreting type 1 T helper (Th1) cells. Further, we assessed the capacity of the electroporated DCs to activate naive HLA-A2-restricted MelanA-specific CD8(+) T cells without the addition of any exogenous cytokines. When all three molecules were combined, a >500-fold increase in MelanA-specific CD8(+) T cells was observed when compared with immature DCs, and a >200-fold increase when compared with cytokine cocktail-matured DCs. In correlation, we found a marked increase in cytolytic and IFN-gamma/tumor necrosis factor-alpha (TNF-alpha) secreting CD8(+) T cells. Our data indicate that immature DCs genetically modified to express stimulating molecules can induce tumor antigen-specific T cells in vitro and could prove to be a significant improvement over DCs matured with the methods currently in use.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD70,
http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A2 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/TLR4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Toll-Like Receptor 4,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1525-0024
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1170-80
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18431362-Antigens, CD70,
pubmed-meshheading:18431362-CD40 Ligand,
pubmed-meshheading:18431362-CD8-Positive T-Lymphocytes,
pubmed-meshheading:18431362-Cell Differentiation,
pubmed-meshheading:18431362-Dendritic Cells,
pubmed-meshheading:18431362-Electroporation,
pubmed-meshheading:18431362-HLA-A2 Antigen,
pubmed-meshheading:18431362-Humans,
pubmed-meshheading:18431362-Interferon-gamma,
pubmed-meshheading:18431362-K562 Cells,
pubmed-meshheading:18431362-Models, Biological,
pubmed-meshheading:18431362-T-Lymphocytes,
pubmed-meshheading:18431362-Th1 Cells,
pubmed-meshheading:18431362-Toll-Like Receptor 4,
pubmed-meshheading:18431362-Tumor Necrosis Factor-alpha
|
pubmed:year |
2008
|
pubmed:articleTitle |
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA.
|
pubmed:affiliation |
Laboratory of Molecular and Cellular Therapy, Department of Physiology-Immunology, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium. aude.bonehill@vub.ac.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|